Intravenous Thrombolysis With or Without Endovascular Treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors.
Katharina SeystahlNicolas Martinez-MajanderAlexander SalernoMorin BeyelerHebun ErdurJoão Pedro MartoChristian HametnerMaria Luisa ZeddeAlessandro PezziniRonen R LekerValerian L AltersbergerGianluca CostamagnaMiguel SerôdioLudovica MigliaccioRosario PascarellaAndrea ZiniLaura MannismäkiYannick BéjotSimon JungHenrik GensickeVisnja PadjenPeter A RinglebChristian H NolteMirjam Rachel HeldnerPatrik MichelStefan T EngelterSami CurtzeMichael WellerSusanne WegenerPublished in: Neurology (2023)
In our dataset from routine clinical care, we provide insights on the safety of IVT for suspected ischemic stroke in patients with intracranial tumors, a population that is commonly withheld thrombolysis in clinical practice and prospective trials. Except for a potential high risk of symptomatic ICH after IVT in patients with tumors of the pituitary region, frequencies of symptomatic ICH in patients with intracranial tumors in our cohort appear to be in the upper range of rates observed in previous studies within the TRISP cooperation. These results may guide individual treatment decisions in patients with acute stroke and intracranial tumors with potential benefit of IVT.